FGF21 and myeloid sarcoma: Conclusion: While the elevated serum FGF21 level was found in subjects with insulin resistantstates, however, this study revealed that serum FGF21 levels were not significantly increasedin renal transplanted recipients with MS as compared with non-MS group.